SCHEMBL13078144

SCHEMBL13078144

C=C1OC(C)(C)C(=O)C(c2nc(-c3ccc(Cl)s3)sc2C)C1=O

nearest known ligand 0.34

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ PTGS1 P23219 1/20 0.31
▸ PTGS2 P35354 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13041497 0.86 PTGS1 (0.33) PTGS1PTGS2
SCHEMBL13077792 0.82 KDM4E (0.38) —
SCHEMBL13078091 0.76 — —
SCHEMBL13077787 0.75 — —
SCHEMBL13077789 0.73 NMUR2 (0.30) —
SCHEMBL10237975 0.71 MAPT (0.36) PTGS1PTGS2
SCHEMBL13058516 0.71 MAPT (0.32) PTGS1PTGS2
SCHEMBL13041400 0.68 RAB9A (0.40) —
SCHEMBL13077790 0.67 L3MBTL1 (0.43) —
SCHEMBL13041474 0.67 KDM4E (0.41) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100279868-A1 NOVEL HERBICIDES SYNGENTA CROP PROTECTION, INC. (US) 2010-11-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100279868-A1 NOVEL HERBICIDES DDT, HPD, HSD17B1 PTGS1 1634/4885PTGS2 1319/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback